- BAP’s FY17 result was above Morgans and consensus estimates at every line with the group ultimately exceeding the top end of its guidance range.
- Management is comfortable with FY18 consensus estimates, guiding to c30% growth on FY17 proforma NPAT. We comfortably sit 2% above this.
- BAP often gets criticised for being overly acquisitive, but the proof is in the pudding with all acquisitions exceeding targets to-date and synergies flowing through nicely.
- BAP will now move into a consolidation phase following this acquisitive period and there is plenty more upside from business optimisation on the agenda.
FY17 result beats with 36.4% EPS growth
BAP’s FY17 result was above our forecast at every line item with the group achieving slightly above the top-end of its guidance range. Highlights of the result include: revenue +47.8%; proforma EBITDA +52.4%; and proforma NPAT +50.9% - buoyed by recent acquisitions (notably Hellaby’s, but also strong growth in each of base businesses). Trade SSS growth remained buoyant at +4.6% (+5%/4.2% 1H/2H) while Retail SSS growth was no worse than feared at +2% (+2.8%/+1.2% 1H/2H).
FY18 guidance for 30% growth….risk to the upside in our view
BAP noted it is comfortable with current consensus forecasts and guided to c30% growth on FY17 proforma NPAT (A$65.8m), which would equate to cA$85.5m FY18 NPAT. We currently forecast A$86.9m FY18 NPAT, equating to 32% growth which we are comfortable with. Accounting for an additional 6 months of HBY Auto and guided ANA/HBY synergies, our FY18 EBITDA forecast only requires c10% growth from the base business which will be readily achievable, in our view. Our EPS forecasts are unchanged in FY18+ (<1%).
Hard to ignore the broad-based growth; Add maintained
Today’s result was a strong reminder of the broad-based growth BAP is achieving and provides us with even more confidence in the group’s growth profile. While the market has been critical of BAP’s acquisition ‘aggression’ in the past, the group’s track record speaks for itself – with all acquisitions exceeding targets and meaningful synergies flowing through.
Morgans clients can login to view our detailed report and upgraded share price target for Bapcor (BAP). Alternatively, please contact your nearest Morgans office for access.
Disclaimer(s): Analyst owns shares.
The information contained in this report is provided to you by Morgans Financial Limited as general advice only, and is made without consideration of an individual's relevant personal circumstances. Morgans Financial Limited ABN 49 010 669 726, its related bodies corporate, directors and officers, employees, authorised representatives and agents (“Morgans”) do not accept any liability for any loss or damage arising from or in connection with any action taken or not taken on the basis of information contained in this report, or for any errors or omissions contained within. It is recommended that any persons who wish to act upon this report consult with their Morgans investment adviser before doing so.